MGI makes its mark in Dubai with latest Platforms at MEDLAB Middle East and Arab Health

MGI makes its mark in Dubai with latest Platforms at MEDLAB Middle East and Arab Health

DUBAI, UAE/PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, will introduce many of its latest gene sequencing platforms and sample preparation system at MEDLAB Middle East 2023, taking place 6-9 February in Dubai. Ahead of the event, MGI will host a demonstration of the innovative robotic ultrasound system MGIUS-R3 at Arab Health, taking place from today until 2 February also in Dubai.

"We are excited to launch three new products at MEDLAB Middle East, including DNBSEQ-G99*, our latest model of gene sequencer* with mid to low range throughput, DNBSEQ-E25, a portable sequencer with very low throughput, as well as DNBelab-D4 digital sample preparation system. In addition, our MGISP-100 automated sample preparation system will be on display for visitors interested to learn more," said Dr. Roy Tan, General Manager of MGI Asia Pacific. "Once again, MGI showcases the commitment to supporting healthcare, scientific research and applications across the Middle East through our genomic technologies."

As one of the sequencers* with the fastest speed among those with the same throughput in the world, DNBSEQ-G99* is developed based on MGI's core DNBSEQTM sequencing technology. It for the first time adopts triangular matrix signal